Abstract:BACKGROUND:Insulin resistance of pancreatic β-cell itself may be a potential link between systemic insulin resistance and impaired insulin secretion in Type 2 diabetes. Protein tyrosine phosphatase 1B (PTP1B) dephosphorylates tyrosine residues in insulin receptors (IR) and IR substrate (IRS) proteins, and thereby inhibits insulin signaling. Thus the impact of PTP1B expression on β-cell insulin pathway may affect insulin secretory function.AIM:The aim of the present study was to investigate the effects of intra-islet inhibition of PTP1B expression on glucose-stimulated insulin secretion and potential mechanisms in rats fed a high-fat diet (HFD).MATERIALS AND METHODS:Twenty 10-week-old Sprague Dawley rats were randomly assigned to a regular diet (RD) or a HFD for 8 weeks. At the end of the 8th week, fasting glucose, fasting insulin concentration and lipid profile were measured and an oral glucose tolerance test was done after 12-h fast. Then islet isolation was performed for static incubation and perifusion. Recombinant adenoviruses containing siPTP1B (Ad-siPTP1B), or siControl (Ad-siControl) sequences were constructed using AdEasy™ system. Islets were transfected and then assigned to the Ad-siPTP1B group, the Ad-siControl group, and mock control group. Real-time RT-PCR and Western blot were used to evaluate the expression level of PTP1B. Western blot of glucose transporter 2 (GLUT-2) and glucokinsase were also done to investigate the β-cell glucose-sensing apparatus. Islets were incubated with Krebs-Ringer bicarbonate containing 2.8 mmol/l glucose then 16.7 mmol/l glucose to evaluate glucose-stimulated insulin secretion (GSIS). Islet perifusion was also performed to evaluate kinetics of insulin release in vitro.RESULTS:HFD rats manifested modest glucose intolerance compared with RD group. And PTP1B expression in isolated islets of rats in the HFD group was higher than that of the RD group. GSIS was impaired in islets of HFD rats (2.3±0.5-fold as basal for HFD vs 8.1±1.3-fold for RD; p<0.05). Ad-siPTP1B treatment resulted in 73% decrease in PTP1B mRNA levels and 61% decrease in PTP1B protein compared with islets treated with Ad-siControl (p<0.05). Simultaneously, PTP1B inhibition resulted in 4.7±0.8-fold increase of GSIS from basal (vs 1.9±0.1-fold for Ad-siControl, p<0.05). Perifusion showed notable improvement of first-phase insulin secretion by AdsiPTP1B treatment. Significant decrease of both GLUT-2 (by 49.8%) and glucokinase (GCK, by 43.7%) were found in the HFD group when compared with the RD group, while up-regulation of both GLUT-2 (by 98%) and GCK (by 62%) was achieved after PTP1B inhibiton by Ad-siPTP1B.CONCLUSIONS:Intra-islet PTP1B is an important physiological regulator of glucose-induced insulin release and the characteristics of PTP1B inhibitors in insulin secretion could make it a potential novel therapeutics for protection of β-cell secretory function in Type 2 diabetes.

Sfrp5 Mediates Glucose-Induced Proliferation in Rat Pancreatic Β-Cells.

Central Sfrp5 Regulates Hepatic Glucose Flux and VLDL-triglyceride Secretion

Glucose Metabolism-Related Protein 1 (GMRP1) Regulates Pancreatic Beta Cell Proliferation and Apoptosis Via Activation of Akt Signalling Pathway in Rats and Mice

Follicle-stimulating Hormone Orchestrates Glucose-Stimulated Insulin Secretion of Pancreatic Islets.

Effect of metformin on SFRP5 release and insulin resistance in diabetic rat

The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation, and type 2 diabetes mellitus

Role of Peroxisome Proliferator-Activated Receptor Gamma in Glucose-Induced Insulin Secretion

Sphingosine‑1‑phosphate Induces Islet Β‑cell Proliferation and Decreases Cell Apoptosis in High‑fat Diet/streptozotocin Diabetic Mice

Circulating Sfrp5 is a Signature of Obesity-Related Metabolic Disorders and is Regulated by Glucose and Liraglutide in Humans

Glucose-mediated Repression of Menin Promotes Pancreatic Β-Cell Proliferation.

Ghrelin Promotes Proliferation and Inhibits Apoptosis of Pancreatic Β Cells

IGF-I Stimulates CCN5/WISP2 Gene Expression in Pancreatic Β-Cells, Which Promotes Cell Proliferation and Survival Against Streptozotocin.

∆nFGF1 Protects β-Cells against High Glucose-Induced Apoptosis via the AMPK/SIRT1/PGC-1α Axis

∆nFGF1 Protects β-Cells against High Glucose-Induced Apoptosis via the AMPK/SIRT1/PGC-1 α Axis

Growth receptor binding protein 10 inhibits glucose-stimulated insulin release from pancreatic β-cells associated with suppression of the insulin/insulin-like growth factor-1 signalling pathway.

RIG-I inhibits pancreatic β cell proliferation through competitive binding of activated Src

Effect of Glucagon-Like Peptide 1 on the Proliferation and Apoptosis of Rat Pancreatic Islet

Improved Glucose-Stimulated Insulin Secretion by Intra-Islet Inhibition of Protein-Tyrosine Phosphatase 1b Expression in Rats Fed A High-Fat Diet

Rig-I Inhibits Pancreatic Beta Cell Proliferation Through Competitive Binding Of Activated Src

Insulin Improves Β-Cell Function in Glucose-Intolerant Rat Models Induced by Feeding a High-Fat Diet.

Ghrelin Regulates the Proliferation and Apoptosis of High Glucose‐induced Islet Cells Through the PI3K–Akt Signaling Pathway